J
John Concato
Researcher at Yale University
Publications - 251
Citations - 30777
John Concato is an academic researcher from Yale University. The author has contributed to research in topics: Population & Prostate cancer. The author has an hindex of 61, co-authored 241 publications receiving 26637 citations. Previous affiliations of John Concato include Boston University & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Thrombocytopenia and in-hospital mortality risk among ischemic stroke patients.
Jason J. Sico,Michael S. Phipps,Michael S. Phipps,John Concato,John Concato,Carolyn K. Wells,Carolyn K. Wells,Albert C. Lo,Albert C. Lo,Albert C. Lo,Steven E. Nadeau,Steven E. Nadeau,Linda S. Williams,Linda S. Williams,Aldo J. Peixoto,Aldo J. Peixoto,Mark Gorman,John L. Boice,John L. Boice,Dawn M. Bravata,Dawn M. Bravata +20 more
TL;DR: Admission thrombocytopenia among patients presenting with acute ischemic stroke predicts in-hospital mortality, and logistic regression modeling evaluated the adjusted association between thromBocytopENia, defined as platelets <100,000/μL, and in- hospital mortality.
Journal ArticleDOI
Consistency of Recall for Deployment-Related Traumatic Brain Injury
Michael L. Alosco,Mihaela Aslan,Mengtian Du,John Ko,Laura J. Grande,Susan P. Proctor,John Concato,Jennifer J. Vasterling +7 more
TL;DR: Deployment-related TBI may not be reported reliably over time, particularly among war-zone veterans with greater PTSD symptoms, particularly in soldiers and veterans deployed to Iraq.
Journal ArticleDOI
A nested case-control study of the effectiveness of screening for prostate cancer: Research design
John Concato,John Concato,Peter Peduzzi,Peter Peduzzi,Ayumi Kamina,Ralph I Horwitz,Ralph I Horwitz +6 more
TL;DR: The methodological aspects of a nested case-control study addressing the question of whether PSA screening, with or without DRE, is effective in increasing survival are described.
Journal ArticleDOI
Boning up on estrogen: new options, new concerns.
TL;DR: Estrogen replacement effectively abrogates this increase in bone breakdown and appears to decrease fracture rates and is the standard for treatment of postmenopausal osteoporosis and the only drug with labeling approval for its prevention.
Journal ArticleDOI
Genome‐wide association study of cognitive performance in U.S. veterans with schizophrenia or bipolar disorder
Philip D. Harvey,Ning Sun,Tim B. Bigdeli,Ayman H. Fanous,Mihaela Aslan,Anil K. Malhotra,Qiongshi Lu,Yiming Hu,Boyang Li,Quan Chen,Shrikant Mane,Perry L. Miller,Nallakkandi Rajeevan,Frederick G. Sayward,Kei-Hoi Cheung,Yuli Li,Tiffany A. Greenwood,Raquel E. Gur,David L. Braff,David L. Braff,Mary Brophy,Saiju Pyarajan,Timothy J. O'Leary,Theresa Gleason,Ronald Przygodszki,Sumitra Muralidhar,John Michael Gaziano,John Concato,Hongyu Zhao,Larry J. Siever +29 more
TL;DR: In a diverse cohort of U.S. veterans with SZ or BP, broad overlap of common genetic effects on cognition in the general population is demonstrated, and greater polygenic loading for SZ risk is associated with poorer cognitive performance.